Successful use of mycophenolate mofetil and prednisone in a 14-year-old girl with acquired hemophilia A

• References

• 1 Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981; 45: 200-3.
• 2 Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost 1997; 78: 1463-7.
• 3 Green D, Rademaker AW, Briet E. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thromb Haemost 1993; 70: 753-7.
• 4 Delgado J, Jimenez-Yuste V, Hernandez-Navarro F. et al. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003; 121: 21-35.
• 5 Moraca RJ, Ragni MV. Acquired anti-F.VIII inhibitors in children. Haemophilia 2002; 8: 28-32.
• 6 Filler G, Hansen M, LeBlanc C. et al. Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children. Pediatr Nephrol 2003; 18: 445-9.
• 7 von Depka M, Huth-Kuehne A. Immunoadsorption with anti-immunoglobulin antibodies using Ig Thera- Sorb columns. In: Inhibitors in patients with haemophilia. Blackwell Science Ltd 2002; 199-205.